| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 4 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 4 |
| 2 | TACROLIMUS | 4 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 4 |
| 4 | TACROLIMUS OINTMENT 0.1% | 4 |
| 5 | ADALIMUMAB | 3 |
| 6 | PREDNISOLONE | 3 |
| 7 | PREDNISOLONE ORAL | 3 |
| 8 | PREDNISOLONE ORAL SOLUTION | 3 |
| 9 | ALBUTEROL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LISOCABTAGENE MARALEUCEL | 2 | 0.0023 |
| 1 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| 2 | ROPIVACAINE HYDROCHLORIDE | 1 | 0.0004 |
| 3 | OXYTOCIN | 1 | 0.0003 |
| 4 | SILODOSIN | 1 | 0.0002 |
| 5 | TURMERIC | 1 | 0.0002 |
| 6 | OXCARBAZEPINE | 2 | 0.0001 |
| 7 | AGALSIDASE BETA | 1 | 0.0001 |
| 8 | BLINATUMOMAB | 1 | 0.0001 |
| 9 | MEMANTINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 4 |
| 1 | Corticosteroid [EPC] | 3 |
| 2 | Mood Stabilizer [EPC] | 3 |
| 3 | alpha-Adrenergic Blocker [EPC] | 3 |
| 4 | Aldosterone Antagonist [EPC] | 2 |
| 5 | Interleukin-17A Antagonist [EPC] | 2 |
| 6 | Provitamin D2 Compound [EPC] | 2 |
| 7 | beta-Adrenergic Blocker [EPC] | 2 |
| 8 | Alkylating Drug [EPC] | 1 |
| 9 | Amide Local Anesthetic [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 1 | 0.0003 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 3 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 4 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 7 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
| 8 | alpha-Adrenergic Blocker [EPC] | 3 | 0.0000 |
| 9 | Anti-epileptic Agent [EPC] | 4 | 0.0000 |